Caris Life Sciences Launches a Novel Caris AI Insights Signature to Guide First-Line Therapy Selection and Treatment De-Escalation in Pancreatic Cancer
Go back to Caris Life Sciences Launches a Novel Caris AI Insights Signature to Guide First-Line Therapy Selection and Treatment De-Escalation in Pancreatic Cancer| CACI INTERNATIONAL CLA (NASDAQ: CAI) | Delayed: 18.85 +0.70 (3.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.15 | 52 Week High | $11.53 | |||
| Open | $18.27 | 52 Week Low | $4.83 | |||
| Day High | $19.75 | P/E | 6.39 | |||
| Day Low | $18.02 | EPS | $2.95 | |||
| Volume | 2,268,916 | |||||
